CBS 2019
CBSMD教育中心
English

肺动脉高压

科研文章

荐读文献

Levosimendan Improves Hemodynamics and Exercise Tolerance in PH-HFpEF: Results of the Randomized Placebo-Controlled HELP Trial Sildenafil added to pirfenidone in patients with advanced idiopathic pulmonary fibrosis and risk of pulmonary hypertension: A Phase IIb, randomised, double-blind, placebo-controlled study - Rationale and study design Pulmonary Hypertension Caused by a Coconut Left Atrium Sotatercept for the Treatment of Pulmonary Arterial Hypertension Chronic thromboembolic pulmonary hypertension Transthoracic echocardiography for the evaluation of children and adolescents with suspected or confirmed pulmonary hypertension. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and D6PK Left main coronary artery compression in pulmonary hypertension Factors associated with pulmonary arterial hypertension (PAH) in systemic sclerosis (SSc) ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association Immunotherapy of Endothelin-1 Receptor Type A for Pulmonary Arterial Hypertension
|<< 1 2 3 4 5 6 7 8 >>|

Clinical Trial2006 Jul 4;114(1):48-54.

JOURNAL：Circulation. Article Link

Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study

Galiè N, Beghetti M, Bosentan Randomized Trial of Endothelin Antagonist Therapy-5 (BREATHE-5) Investigators. Keywords: pulmonary hypertension; invasive screening; congenital heart disease; peak oxygen uptake

FULL TEXT PDF

>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top